CN104884621A - 基因工程酵母 - Google Patents
基因工程酵母 Download PDFInfo
- Publication number
- CN104884621A CN104884621A CN201380062761.3A CN201380062761A CN104884621A CN 104884621 A CN104884621 A CN 104884621A CN 201380062761 A CN201380062761 A CN 201380062761A CN 104884621 A CN104884621 A CN 104884621A
- Authority
- CN
- China
- Prior art keywords
- yeast cell
- genetic modification
- seq
- decarboxylase
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 46
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims abstract description 60
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 45
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 40
- 229940000635 beta-alanine Drugs 0.000 claims abstract description 30
- 108090000340 Transaminases Proteins 0.000 claims abstract description 16
- 108020003281 3-hydroxyisobutyrate dehydrogenase Proteins 0.000 claims abstract description 10
- 238000000855 fermentation Methods 0.000 claims abstract description 10
- 230000004151 fermentation Effects 0.000 claims abstract description 9
- 102000006027 3-hydroxyisobutyrate dehydrogenase Human genes 0.000 claims abstract description 8
- 108010053763 Pyruvate Carboxylase Proteins 0.000 claims abstract description 7
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 claims abstract description 6
- 108010003415 Aspartate Aminotransferases Proteins 0.000 claims abstract description 5
- 102000004625 Aspartate Aminotransferases Human genes 0.000 claims abstract description 5
- OAKURXIZZOAYBC-UHFFFAOYSA-M 3-oxopropanoate Chemical compound [O-]C(=O)CC=O OAKURXIZZOAYBC-UHFFFAOYSA-M 0.000 claims abstract 2
- 102000003929 Transaminases Human genes 0.000 claims abstract 2
- 102000004190 Enzymes Human genes 0.000 claims description 25
- 108090000790 Enzymes Proteins 0.000 claims description 25
- 210000005253 yeast cell Anatomy 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 13
- 241000193755 Bacillus cereus Species 0.000 claims description 12
- 210000004027 cell Anatomy 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 9
- 241000254113 Tribolium castaneum Species 0.000 claims description 8
- 241000589776 Pseudomonas putida Species 0.000 claims description 7
- 101150051977 AAT2 gene Proteins 0.000 claims description 6
- 102100033814 Alanine aminotransferase 2 Human genes 0.000 claims description 6
- 101100377784 Arabidopsis thaliana ASP2 gene Proteins 0.000 claims description 6
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 6
- 101150079757 GPT2 gene Proteins 0.000 claims description 6
- 101100354855 Homo sapiens PYDC1 gene Proteins 0.000 claims description 6
- 101100268515 Mus musculus Serpina1b gene Proteins 0.000 claims description 6
- 101150010895 PYC1 gene Proteins 0.000 claims description 6
- 102100039892 Pyrin domain-containing protein 1 Human genes 0.000 claims description 6
- 101100032136 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PYC2 gene Proteins 0.000 claims description 6
- 241000222122 Candida albicans Species 0.000 claims description 5
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 5
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 5
- 229960005261 aspartic acid Drugs 0.000 claims description 5
- 229940095731 candida albicans Drugs 0.000 claims description 5
- 108091022930 Glutamate decarboxylase Proteins 0.000 claims description 4
- 102000008214 Glutamate decarboxylase Human genes 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 101000754919 Homo sapiens Ribosomal oxygenase 2 Proteins 0.000 claims description 3
- 102100022092 Ribosomal oxygenase 2 Human genes 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000005891 transamination reaction Methods 0.000 claims description 3
- 108030003579 Aspartate 1-decarboxylases Proteins 0.000 claims description 2
- 101710088194 Dehydrogenase Proteins 0.000 claims description 2
- 241000157876 Metallosphaera sedula Species 0.000 claims description 2
- 241000205101 Sulfolobus Species 0.000 claims description 2
- 238000012239 gene modification Methods 0.000 claims 12
- 230000005017 genetic modification Effects 0.000 claims 12
- 235000013617 genetically modified food Nutrition 0.000 claims 12
- 102100021388 3-hydroxyisobutyrate dehydrogenase, mitochondrial Human genes 0.000 claims 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims 2
- 108090000489 Carboxy-Lyases Proteins 0.000 claims 1
- 241000205091 Sulfolobus solfataricus Species 0.000 claims 1
- 238000006555 catalytic reaction Methods 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 229940107700 pyruvic acid Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 26
- 108030001569 3-hydroxypropionate dehydrogenases Proteins 0.000 abstract description 13
- 102100026278 Cysteine sulfinic acid decarboxylase Human genes 0.000 abstract description 13
- 108010002447 aspartate-alpha-decarboxylase Proteins 0.000 abstract description 13
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 abstract description 8
- 230000037361 pathway Effects 0.000 abstract description 8
- 241001079784 Bacillus cereus AH1272 Species 0.000 abstract description 4
- 230000003197 catalytic effect Effects 0.000 abstract 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 112
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 239000002609 medium Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 18
- 239000013612 plasmid Substances 0.000 description 17
- 239000008103 glucose Substances 0.000 description 16
- 102000014898 transaminase activity proteins Human genes 0.000 description 14
- 239000012634 fragment Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000013613 expression plasmid Substances 0.000 description 11
- OAKURXIZZOAYBC-UHFFFAOYSA-N 3-oxopropanoic acid Chemical compound OC(=O)CC=O OAKURXIZZOAYBC-UHFFFAOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 9
- 239000011782 vitamin Substances 0.000 description 9
- 235000013343 vitamin Nutrition 0.000 description 9
- 229930003231 vitamin Natural products 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- 229910021654 trace metal Inorganic materials 0.000 description 8
- 150000003722 vitamin derivatives Chemical class 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 102000034279 3-hydroxybutyrate dehydrogenases Human genes 0.000 description 5
- 108090000124 3-hydroxybutyrate dehydrogenases Proteins 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 5
- 101100052858 Bacillus subtilis (strain 168) yhxA gene Proteins 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000008121 dextrose Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- ALRHLSYJTWAHJZ-UHFFFAOYSA-M 3-hydroxypropionate Chemical compound OCCC([O-])=O ALRHLSYJTWAHJZ-UHFFFAOYSA-M 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- 108091081024 Start codon Proteins 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 229960003767 alanine Drugs 0.000 description 4
- 238000001952 enzyme assay Methods 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- 108010010560 Beta-alanine-pyruvate transaminase Proteins 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 229940009098 aspartate Drugs 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 101150116670 gabT gene Proteins 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 229940035893 uracil Drugs 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 229940065734 gamma-aminobutyrate Drugs 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- 108030000921 4-aminobutyrate-2-oxoglutarate transaminases Proteins 0.000 description 1
- 102100026790 Alanine-glyoxylate aminotransferase 2, mitochondrial Human genes 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241000178280 Aureococcus Species 0.000 description 1
- 101150023977 Baat gene Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102100027950 Bile acid-CoA:amino acid N-acyltransferase Human genes 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 101100351264 Candida albicans (strain SC5314 / ATCC MYA-2876) PDC11 gene Proteins 0.000 description 1
- 241000193401 Clostridium acetobutylicum Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 101900256844 Corynebacterium glutamicum Aspartate 1-decarboxylase Proteins 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 102000018976 Cytoplasmic Aspartate Aminotransferase Human genes 0.000 description 1
- 108010026759 Cytoplasmic Aspartate Aminotransferase Proteins 0.000 description 1
- 241000235036 Debaryomyces hansenii Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000360593 Erythroides Species 0.000 description 1
- 101900235484 Escherichia coli Aspartate 1-decarboxylase Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101000697858 Homo sapiens Bile acid-CoA:amino acid N-acyltransferase Proteins 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- 241000235087 Lachancea kluyveri Species 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 101150050255 PDC1 gene Proteins 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 1
- 101100082596 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PDC5 gene Proteins 0.000 description 1
- 101100519200 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PDC6 gene Proteins 0.000 description 1
- 241000789569 Saccharomyces cerevisiae CEN.PK113-7D Species 0.000 description 1
- 235000018370 Saccharomyces delbrueckii Nutrition 0.000 description 1
- 244000253911 Saccharomyces fragilis Species 0.000 description 1
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 1
- 241000235060 Scheffersomyces stipitis Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 101150001810 TEAD1 gene Proteins 0.000 description 1
- 101150074253 TEF1 gene Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 244000288561 Torulaspora delbrueckii Species 0.000 description 1
- 235000014681 Torulaspora delbrueckii Nutrition 0.000 description 1
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- 241000235015 Yarrowia lipolytica Species 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 108010007014 alanine 2,3-aminomutase Proteins 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- -1 coatings Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000000925 erythroid effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012526 feed medium Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229920000247 superabsorbent polymer Polymers 0.000 description 1
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/52—Propionic acid; Butyric acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01031—3-Hydroxyisobutyrate dehydrogenase (1.1.1.31)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01059—3-Hydroxypropionate dehydrogenase (1.1.1.59)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y206/00—Transferases transferring nitrogenous groups (2.6)
- C12Y206/01—Transaminases (2.6.1)
- C12Y206/01001—Aspartate transaminase (2.6.1.1), i.e. aspartate-aminotransferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01011—Aspartate 1-decarboxylase (4.1.1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01015—Glutamate decarboxylase (4.1.1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y604/00—Ligases forming carbon-carbon bonds (6.4)
- C12Y604/01—Ligases forming carbon-carbon bonds (6.4.1)
- C12Y604/01001—Pyruvate carboxylase (6.4.1.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12188198 | 2012-10-11 | ||
| EP12188198.1 | 2012-10-11 | ||
| PCT/EP2013/071163 WO2014057036A1 (en) | 2012-10-11 | 2013-10-10 | Genetically engineered yeast |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104884621A true CN104884621A (zh) | 2015-09-02 |
Family
ID=47018877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380062761.3A Pending CN104884621A (zh) | 2012-10-11 | 2013-10-10 | 基因工程酵母 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9868966B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2906701B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2015531237A (cg-RX-API-DMAC7.html) |
| CN (1) | CN104884621A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015008111A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2888093A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014057036A1 (cg-RX-API-DMAC7.html) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105385614A (zh) * | 2015-12-17 | 2016-03-09 | 浙江大学 | 一种重组酿酒酵母及其构建方法与应用 |
| CN114276970A (zh) * | 2021-12-31 | 2022-04-05 | 北京化工大学 | 一种产1,3-丙二醇的基因工程菌 |
| CN117070435A (zh) * | 2021-12-06 | 2023-11-17 | 中国科学院天津工业生物技术研究所 | 来自Clostridioides difficile的L-谷氨酸-2,3-氨基变位酶在合成β-丙氨酸中的应用 |
| CN117384933A (zh) * | 2023-12-12 | 2024-01-12 | 珠海麦得发生物科技股份有限公司 | 利用木糖生产3-羟基丙酸的菌株及其构建方法和应用 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9845484B2 (en) | 2013-07-31 | 2017-12-19 | Novozymes A/S | 3-hydroxypropionic acid production by recombinant yeasts expressing an insect aspartate 1-decarboxylase |
| US20180273915A1 (en) * | 2014-12-19 | 2018-09-27 | Novozymes A/S | Recombinant Host Cells For The Production Of 3-Hydroxypropionic Acid |
| WO2016100910A1 (en) * | 2014-12-19 | 2016-06-23 | Novozymes A/S | Recombinant host cells for the production of 3-hydroxypropionic acid |
| KR101828551B1 (ko) * | 2016-01-11 | 2018-02-13 | 한국과학기술원 | 말론산 생성능을 가지는 재조합 변이미생물 및 이를 이용한 말론산의 제조방법 |
| CN107828714A (zh) * | 2017-12-19 | 2018-03-23 | 江南大学 | 一株异源表达L‑天冬氨酸‑α‑脱羧酶的大肠杆菌重组菌 |
| US20190233850A1 (en) * | 2018-02-01 | 2019-08-01 | Invista North America S.A.R.L. | Methods and materials for the biosynthesis of beta hydroxy acids and derivatives and compounds related thereto |
| US10947548B2 (en) * | 2018-04-24 | 2021-03-16 | Battelle Memorial Institute | Production of organic acids from Aspergillus cis-aconitic acid decarboxylase (cadA) deletion strains |
| WO2020127506A1 (en) * | 2018-12-18 | 2020-06-25 | Alderys | Malonic semi-aldehyde-producing yeasts |
| BR112021021777A2 (pt) * | 2019-04-30 | 2022-02-08 | Univ Danmarks Tekniske | Métodos para a produção de ergotioneína |
| US11873523B2 (en) | 2020-06-15 | 2024-01-16 | Battelle Memorial Institute | Aconitic acid exporter (aexA) increases organic acid production in Aspergillus |
| CN115261364B (zh) * | 2021-03-03 | 2024-05-31 | 广安摩珈生物科技有限公司 | 改善β-丙氨酸生产的昆虫源性天冬氨酸脱羧酶及其变体 |
| KR102838362B1 (ko) * | 2022-03-18 | 2025-07-23 | 씨제이제일제당 (주) | 거짓쌀도둑거저리 유래 아스파테이트 1-디카복실라아제의 활성이 강화된 미생물, 및 이의 용도 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852517B1 (en) * | 1999-08-30 | 2005-02-08 | Wisconsin Alumni Research Foundation | Production of 3-hydroxypropionic acid in recombinant organisms |
| WO2005118719A2 (en) * | 2003-12-04 | 2005-12-15 | Cargill, Incorporated | Production of 3-hydroxypropionic acid using beta-alanine/pyruvate aminotransferase |
| WO2010031083A2 (en) * | 2008-09-15 | 2010-03-18 | Opx Biotechnologies, Inc. | Methods, systems and compositions related to reduction of conversions of microbially produced 3-hydroxypropionic acid (3-hp) to aldehyde metabolites |
| US20120135481A1 (en) * | 2010-11-22 | 2012-05-31 | Novozymes, Inc. | Compositions and methods for 3-hydroxypropionic acid production |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8673601B2 (en) * | 2007-01-22 | 2014-03-18 | Genomatica, Inc. | Methods and organisms for growth-coupled production of 3-hydroxypropionic acid |
| BRPI0908946A2 (pt) * | 2008-03-11 | 2018-02-27 | Dsm Ip Assets Bv | síntese de éster ou de tioéster de adipato |
| US20120231512A1 (en) * | 2009-09-11 | 2012-09-13 | Dsm Ip Assets B.V. | Preparation of alpha-ketopimelic acid |
| JP2012085635A (ja) * | 2010-03-23 | 2012-05-10 | Nippon Shokubai Co Ltd | 3−ヒドロキシプロピオン酸の製造方法 |
-
2013
- 2013-10-10 WO PCT/EP2013/071163 patent/WO2014057036A1/en not_active Ceased
- 2013-10-10 CA CA2888093A patent/CA2888093A1/en not_active Abandoned
- 2013-10-10 EP EP13774663.2A patent/EP2906701B1/en not_active Not-in-force
- 2013-10-10 BR BR112015008111A patent/BR112015008111A2/pt not_active IP Right Cessation
- 2013-10-10 CN CN201380062761.3A patent/CN104884621A/zh active Pending
- 2013-10-10 JP JP2015536127A patent/JP2015531237A/ja not_active Ceased
- 2013-10-10 US US14/435,111 patent/US9868966B2/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852517B1 (en) * | 1999-08-30 | 2005-02-08 | Wisconsin Alumni Research Foundation | Production of 3-hydroxypropionic acid in recombinant organisms |
| WO2005118719A2 (en) * | 2003-12-04 | 2005-12-15 | Cargill, Incorporated | Production of 3-hydroxypropionic acid using beta-alanine/pyruvate aminotransferase |
| WO2010031083A2 (en) * | 2008-09-15 | 2010-03-18 | Opx Biotechnologies, Inc. | Methods, systems and compositions related to reduction of conversions of microbially produced 3-hydroxypropionic acid (3-hp) to aldehyde metabolites |
| WO2010031083A3 (en) * | 2008-09-15 | 2010-07-08 | Opx Biotechnologies, Inc. | Methods, systems and compositions related to reduction of conversions of microbially produced 3-hydroxypropionic acid (3-hp) to aldehyde metabolites |
| US20120135481A1 (en) * | 2010-11-22 | 2012-05-31 | Novozymes, Inc. | Compositions and methods for 3-hydroxypropionic acid production |
Non-Patent Citations (1)
| Title |
|---|
| 无: "C2ZAL1", 《UNIPROT》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105385614A (zh) * | 2015-12-17 | 2016-03-09 | 浙江大学 | 一种重组酿酒酵母及其构建方法与应用 |
| CN105385614B (zh) * | 2015-12-17 | 2018-07-24 | 浙江大学 | 一种重组酿酒酵母及其构建方法与应用 |
| CN117070435A (zh) * | 2021-12-06 | 2023-11-17 | 中国科学院天津工业生物技术研究所 | 来自Clostridioides difficile的L-谷氨酸-2,3-氨基变位酶在合成β-丙氨酸中的应用 |
| CN114276970A (zh) * | 2021-12-31 | 2022-04-05 | 北京化工大学 | 一种产1,3-丙二醇的基因工程菌 |
| CN114276970B (zh) * | 2021-12-31 | 2023-06-27 | 北京化工大学 | 一种产1,3-丙二醇的基因工程菌 |
| CN117384933A (zh) * | 2023-12-12 | 2024-01-12 | 珠海麦得发生物科技股份有限公司 | 利用木糖生产3-羟基丙酸的菌株及其构建方法和应用 |
| CN117384933B (zh) * | 2023-12-12 | 2024-04-02 | 珠海麦得发生物科技股份有限公司 | 利用木糖生产3-羟基丙酸的菌株及其构建方法和应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014057036A1 (en) | 2014-04-17 |
| US9868966B2 (en) | 2018-01-16 |
| BR112015008111A2 (pt) | 2017-11-28 |
| CA2888093A1 (en) | 2014-04-17 |
| EP2906701A1 (en) | 2015-08-19 |
| JP2015531237A (ja) | 2015-11-02 |
| US20150267228A1 (en) | 2015-09-24 |
| EP2906701B1 (en) | 2018-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2906701B1 (en) | Genetically engineered yeast | |
| US11505811B2 (en) | Method for the preparation of 2,4-dihydroxybutyrate | |
| CA2862790C (en) | A recombinant carboxydotrophic acetogenic microorganism and uses thereof in microbial fermentation | |
| Chen et al. | Metabolic engineering of Corynebacterium glutamicum for the de novo production of ethylene glycol from glucose | |
| KR20140027541A (ko) | 이산화탄소 고정 경로를 도입한 미생물 | |
| KR20130119945A (ko) | 3-히드록시프로피온산 생산을 위한 조성물 및 방법 | |
| US20170107526A1 (en) | Compositions and Methods for Succinate Production | |
| EP2925873B1 (en) | 3-hydroxypropionic acid production by recombinant yeasts | |
| WO2020128618A2 (en) | Co-production pathway for 3-hp and acetyl-coa derivatives from malonate semialdehyde | |
| JP5142268B2 (ja) | 改良型没食子酸合成酵素および没食子酸の製造法 | |
| JP5320692B2 (ja) | 酵母及びl−乳酸の製造方法 | |
| EP2904104B1 (en) | Recombinant microorganisms for producing organic acids | |
| CN111349644A (zh) | 生物合成异戊二醇的菌株及方法 | |
| JP2009065839A (ja) | 没食子酸の製造法 | |
| US9605283B2 (en) | Microorganism modified for the production of 1,3-propanediol | |
| CN114058560B (zh) | 甘氨酸的生产方法 | |
| CN106190997B (zh) | 一种nadh依赖性的二氨基庚二酸脱氢酶及其应用 | |
| JP2008283917A (ja) | 乳酸の製造方法 | |
| US20240052382A1 (en) | Process control for 3-hydroxypropionic acid production by engineered strains of aspergillus niger | |
| US20260043054A1 (en) | Genetically modified cells of methylobacteriaceae for fermentative production of glycolic acid and lactic acid from cx compounds | |
| WO2012103263A2 (en) | Compositions and methods for malate and fumarate production | |
| WO2025195344A1 (zh) | 2-氨基-4-甲硫基-丁酸或2-羟基-4-甲硫基-丁酸的制备方法 | |
| EP2930244A1 (en) | Microorganisms and methods for producing acrylate and other products from homoserine | |
| CN120591221A (zh) | 二氧化碳固定途径及其在微生物中的应用 | |
| WO2022019949A1 (en) | Enzymes and methods for production of malonic acid and derivatives thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150902 |
|
| RJ01 | Rejection of invention patent application after publication |